Moderne antihypertensive Therapie im Licht der arteriellen Gefäßfunktion

Literatur

• 1 Asmar R. et al . Arterial and antihypertensive effects of nitrendipine: a double-blind comparison versus placebo.  J Cardiovasc Pharmacol. 1992;  20 858-863
  Google Scholar
• 2 Barenbrock M. et al . Effect of lisinopril and metoprolol on arterial distensibility.  Hypertension. 1994;  (Suppl 1) 23 I161-I163
  Google Scholar
• 3 Benetos A. et al . Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population.  Hypertension. 1997;  30 1410-1415
  Google Scholar
• 4 Benetos A, Lacolley P, Safar M E. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats.  Arterioscler Thromb Vasc Biol. 1997;  17 1152-1156
  Google Scholar
• 5 Breithaupt-Grogler K, Belz G G. Epidemiology of the arterial stiffness.  Pathol Biol (Paris). 1999;  47 604-613
  Google Scholar
• 6 Dahlof B. et al . Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.  Lancet. 2002;  359 995-1003
  Google Scholar
• 7 Dahlof B. et al . Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.  Lancet. 2005;  366 895-906
  Google Scholar
• 8 De Cesaris R. et al . Large artery compliance in essential hypertension: Effects of calcium antagonism and beta-blocking.  Am J Hypertens. 1992;  5 624-628
  Google Scholar
• 9 Franklin S S. et al . Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study.  Circulation. 1997;  96 308-315
  Google Scholar
• 10 Franklin S S. et al . Predictors of new-onset diastolic and systolic hypertension: the Framingham Heart Study.  Circulation. 2005;  111 1121-1127
  Google Scholar
• 11 Franklin S S. et al . Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III.  Hypertension. 2001;  37 869-874
  Google Scholar
• 12 Guerin A P. et al . Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure.  Circulation. 2001;  103 987-992
  Google Scholar
• 13 Hirata K. et al . Benefits from angiotensin-converting enzyme inhibitor „beyond blood pressure lowering” beyond blood pressure or beyond the brachial artery?.  J Hypertens. 2005;  23 551-556
  Google Scholar
• 14 Keil U. et al . Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984 - 1992. Monitoring Trends and Determinants in Cardiovascular Diseases.  Eur Heart J. 1998;  19 1197-1207
  Google Scholar
• 15 Kelly R. et al . Arterial dilation and reduced wave reflection. Benefit of dilevalol in hypertension.  Hypertension. 1989;  14 14-21
  Google Scholar
• 16 Levy B I. et al . Sodium, survival, and the mechanical properties of the carotid artery in stroke-prone hypertensive rats.  J Hypertens. 1997;  15 251-258
  Google Scholar
• 17 Lickvers K. et al . n deutscher Titel (DKV).  Dtsch Med Wochenschr. 2005;  130 2628-2630
  Google Scholar
• 18 Lloyd-Jones D M. et al . Differential impact of systolic and diastolic blood pressure level on JNC-VI staging. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.  Hypertension. 1999;  34 381-385
  Google Scholar
• 19 London G M. et al . Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition.  J Hypertens. 1996;  14 1139-1146
  Google Scholar
• 20 London G M. et al . Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol.  J Am Coll Cardiol. 2004;  43 92-99
  Google Scholar
• 21 Magometschnigg D. Blood pressure and arterial stiffness. A comparison of two devices for measuring augmentationindex and pulse wave velocity.  Wien Med Wochenschr. 2005;  155 404-410
  Google Scholar
• 22 Mahmud A, Feely J. Antihypertensive drugs and arterial stiffness.  Expert Rev Cardiovasc Ther. 2003;  1 65-78
  Google Scholar
• 23 Mahmud A, Feely J. Effect of angiotensin ii receptor blockade on arterial stiffness: beyond blood pressure reduction.  Am J Hypertens. 2002;  15 1092-1095
  Google Scholar
• 24 Mahmud A, Feely J. Reduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibition.  Am J Hypertens. 2002;  15 321-325
  Google Scholar
• 25 Matsuo T. et al . Improvement of arterial stiffness by the antioxidant and anti-inflammatory effects of short-term statin therapy in patients with hypercholesterolemia.  Heart Vessels. 2005;  20 8-12
  Google Scholar
• 26 McEniery C M. et al . Nebivolol increases arterial distensibility in vivo.  Hypertension. 2004;  44 305-310
  Google Scholar
• 27 Morgan T. et al . Effect of different antihypertensive drug classes on central aortic pressure.  Am J Hypertens. 2004;  17 118-123
  Google Scholar
• 28 Nürnberger J. et al . Left ventricular ejection time: a potential determinant of pulse wave velocity in young, healthy males.  J Hypertens. 2003;  21 2125-2132
  Google Scholar
• 29 Nürnberger J. et al . Pulswellenreflektion.  Dtsch Med Wochenschr. 2004;  129 97-102
  Google Scholar
• 30 Opazo Saez A M. et al . Arterial stiffness. A Potential Therapeutic Target to Reduce Cardiovascular Mortality.  Curr Hypertens Rev. 2006;  2 97-102
  Google Scholar
• 31 Pancera P. et al . Haemodynamic parameters in hypertensive patients: changes induced by lacidipine and nifedipine.  J Hypertens Suppl. 1989;  7 S284-S285
  Google Scholar
• 32 Safar M E, Levy B I, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases.  Circulation. 2003;  107 2864-2869
  Google Scholar
• 33 Schwabe U, Paffrath D. Arzneiverordnungs-Report 2005. Heidelberg: Springer-Verlag 2006: 1220
  Google Scholar
• 34 Takenaka T, Suzuki H. New strategy to attenuate pulse wave velocity in haemodialysis patients.  Nephrol Dial Transplant. 2005;  20 811-816
  Google Scholar
• 35 Tanaka H, Safar M E. Influence of lifestyle modification on arterial stiffness and wave reflections.  Am J Hypertens. 2005;  18 137-144
  Google Scholar
• 36 Ting C T. et al . Short- and long-term effects of antihypertensive drugs on arterial reflections, compliance, and impedance.  Hypertension. 1995;  26 524-530
  Google Scholar
• 37 Topouchian J. et al . Changes in arterial structure and function under trandolapril-verapamil combination in hypertension.  Stroke. 1999;  30 1056-1064
  Google Scholar
• 38 White W B. et al . Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension.  Hypertension. 2003;  41 1021-1026
  Google Scholar
• 39 Wilkinson I B. et al . Nitric oxide regulates local arterial distensibility in vivo.  Circulation. 2002;  105 213-217
  Google Scholar
• 40 Williams B. et al . Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.  Circulation. 2006;  113 1213-1225
  Google Scholar
• 41 Wolf-Maier K. et al . Hypertension treatment and control in five European countries, Canada, and the United States.  Hypertension. 2004;  43 10-17
  Google Scholar

Priv.-Doz. Dr. med. Jens Nürnberger

Klinik für Nieren- und Hochdruckkrankheiten, Universitätsklinikum Essen

Hufelandstraße 55

45122 Essen

Phone: 0201/7233390

Fax: 0201/7233393

Email: jens.nuernberger@uni-duisburg-essen.de